[
  {
    "ts": null,
    "headline": "Large-cap biotech is a sector to watch for investors: Analysts",
    "summary": "Large-cap biotechs are a potential new asset class as China and D.C. pressure Big Pharma to invest elsewhere.",
    "url": "https://finnhub.io/api/news?id=0662f07a31d05278cb660cdf2621d1dc4a73cf29cd67af073f9e563f506cfd9c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756644000,
      "headline": "Large-cap biotech is a sector to watch for investors: Analysts",
      "id": 136588775,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Large-cap biotechs are a potential new asset class as China and D.C. pressure Big Pharma to invest elsewhere.",
      "url": "https://finnhub.io/api/news?id=0662f07a31d05278cb660cdf2621d1dc4a73cf29cd67af073f9e563f506cfd9c"
    }
  }
]